Reply to:Experimental aspects of copy number variant assays at CCL3L1

Nature Medicine

Volumn 15, Issue 10, 2009, Pages 1117-1120

  He, Weijing ^a,b   Kulkarni, Hemant ^a,b   Castiblanco, John ^a,b   Shimizu, Chisato ^c   Aluyen, Una ^a,b   Maldonado, Robert ^a,b   Carrillo, Andrew ^a,b   Griffin, Madeline ^a,b   Lipsitt, Amanda ^a,b   Beachy, Lisa ^a,b   Shostakovich Koretskaya, Ludmila ^d   Mangano, Andrea ^e   Sen, Luisa ^e   Nibbs, Robert J B ^f   Tiemessen, Caroline T ^g   Bolivar, Hector ^h   Bamshad, Michael J ⁱ   Clark, Robert A ^a,b   Burns, Jane C ^c   Dolan, Matthew J ^j,k   Ahuja, Sunil K ^a,b   more..

^a SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d Dnipropetrovsk State Medical Academy   (Ukraine)

^e HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

^g UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^h UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^k SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CHEMOKINE; TETRAMETHYLRHODAMINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ASSAY; CD4+ T LYMPHOCYTE; CELL COUNT; DISEASE COURSE; DISEASE PREDISPOSITION; GENE DUPLICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ALGORITHMS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL ASSAY; CASE-CONTROL STUDIES; CHEMOKINES, CC; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 3; CLUSTER ANALYSIS; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; DNA; DNA PROBES; ETHNIC GROUPS; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; GREAT BRITAIN; HIV INFECTIONS; HIV-1; HUMANS; LIGANDS; POLYMERASE CHAIN REACTION; POPULATION GROUPS; RECEPTORS, CCR5; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; TERMINAL REPEAT SEQUENCES;

EID: 70350439651     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1009-1117     Document Type: Letter

References (18)

1. Urban, T.J. et al. Nat. Med. 15, 1110-1112 (2009).
2. Bhattacharya, T. et al. Nat. Med. 15, 1112-1115 (2009).
3. Field, S.F. et al. Nat. Med. 15, 1115-1117 (2009).
4. Ahuja, S.K. et al. Nat. Med. 14, 413-420 (2008).
5. Gonzalez, E. et al. Science 307, 1434-1440 (2005).
6. Townson, J.R., Barcellos, L.F. & Nibbs, R.J. Eur. J. Immunol. 32, 3016-3026 (2002).
7. Shostakovich-Koretskaya, L. et al. AIDS 23, 679-688 (2009).
8. Dolan, M.J. et al. Nat. Immunol. 8, 1324-1336 (2007).
9. Guérin, S. et al. AIDS 14, 2788-2790 (2000).
10. Yamashita, T.E. et al. AIDS 15, 735-746 (2001)
11. Valdez, H., Purvis, S.F., Lederman, M.M., Fillingame, M. & Zimmerman, P.A. J. Am. Med. Assoc. 282, 734 (1999).
12. Hendrickson, S.L. et al. J. Acquir. Immune Defic. Syndr. 48, 263-271 (2008).
13. Kasten, S. et al. Eur. J. Med. Res. 5, 323-328 (2000).
14. Colobran, R. et al. Genes Immun. 9, 279-288 (2008).
15. Perry, G.H. et al. Am. J. Hum. Genet. 82, 685-695 (2008).
16. Alkan, C. et al. Nat. Genet. advance online publication, doi:10.1038/ng.437 (30 August 2009).
17. Gornalusse, G. et al. PLoS Genet. 5, e1000359 (2009).
18. Degenhardt, J.D. et al. PLoS Genet. 5, e1000346 (2009)